Fig. 2From: Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapyCumulative incidence rate of radiation neuropathy for those with gross tumor volume < 64.5 ml vs. ≥ 64.5 mlBack to article page